12th C1-Inhibitor Deficiency Angioedema Workshop
Jun 4, 2021 9:45 AM CEST
The company will present preclinical data for PHA121 at the 12th C1-Inhibitor Deficiency Angioedema Workshop, to be held virtually from June 3-6, 2021. The abstract, titled “PHA-022121: Efficacy in a monkey bradykinin challenge model translated to human,” has been accepted for oral presentation by Anne Lesage, Ph.D., chief early development officer of Pharvaris, in Session 1, Basic Research and Diagnostics, on June 4 at 9:45 a.m. CEST.